September 20, 2017
LA JOLLA—Silvana Konermann, a research associate in the lab of Helmsley-Salk Fellow Patrick Hsu, was chosen as one of 15 inaugural Howard Hughes Medical Institute Hanna H. Gray Fellows. Each fellow will receive up to $1.4 million in funding over eight years.
Haga clic aquí for a high-resolution image
Image courtesy of HHMI
“Silvana’s research at the intersection of genome engineering and neurobiology is both brave and creative, and holds incredible promise for illuminating some of the genetic underpinnings of neurodegeneration,” says Hsu. “This support will help her continue to think big, and to solve important problems in biology.”
Konermann, who received her PhD in neuroscience from MIT, aims to use powerful genetic tools to untangle the complex web of genes that predispose a person to Alzheimer’s disease. A gene called APOE is one of the strongest risk factors for the devastating neurodegenerative disease. One variant of the gene is protective while another increases risk. By systematically knocking out parts of the genome with the gene-editing tool CRISPR-Cas9, Konermann will hunt for other genes that potentially interact with APOE.
“I am honored to be included in the inaugural group of HHMI Hanna H. Gray Fellows,” says Konermann. “The mission of this amazing program to increase the diversity and representation of women and minorities through long-term support of young scientists is critical and tremendously appreciated. This support from HHMI will allow me to pursue the high-risk, high-reward science I am passionate about.”
The Hanna H. Gray Fellows program seeks to increase diversity in the biomedical research community by supporting talented early career scientists from groups underrepresented in the life sciences who have the potential to become leaders in academic research. In this two-phase program, fellows will be supported from early postdoctoral training through several years of a tenure-track faculty position.
The program is named for Hanna Holborn Gray, former chair of the HHMI Trustees and former president of the University of Chicago. Under Gray’s leadership, HHMI developed initiatives that foster diversity in science education.
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.
